Xeris Biopharma Holdings (XERS) Shares Outstanding (Entity) (2020 - 2026)

Xeris Biopharma Holdings (XERS) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Outstanding (Entity.) (Qtr)
1	Haleon	43.76 Bn	42.79 Bn	-	4.44 Bn
2	Teva Pharmaceutical Industries	43.38 Bn	39.73 Bn	2.15 Bn	1.17 Bn
3	Zoetis	31.61 Bn	29.93 Bn	1.05 Bn	414.15 Mn
4	Takeda Pharmaceutical	28.64 Bn	22.84 Bn	5.10 Bn	-
5	United Therapeutics	22.20 Bn	19.54 Bn	683.80 Mn	42.68 Mn
6	Viatris	18.82 Bn	17.93 Bn	1.46 Bn	1.15 Bn
7	Neurocrine Biosciences	15.67 Bn	15.28 Bn	935.80 Mn	101.60 Mn
8	Elanco Animal Health	12.11 Bn	11.58 Bn	798.00 Mn	499.55 Mn
9	Dr Reddys Laboratories	10.10 Bn	9.94 Bn	-	834.66 Mn
10	Xeris Biopharma Holdings	1.50 Bn	1.38 Bn	79.59 Mn	173.59 Mn

Download Data